Pressmeddelande -
SARomics Biostructures and Vectron Biosolutions announce joint service offering
Lund, Sweden & Trondheim, Norway, December 20, 2010 – SARomics Biostructures and Vectron Biosolutions announced today that they have partnered to offer a joint service to the life science industry. This service will cover customized gene to structure projects and will utilize Vectron Biosolutions expertise in protein production and SARomics Biostructures expertise in protein crystallization and structure determination.
Recently, the two companies successfully executed their first gene-to-structure project and they have now formalized their collaboration. Vectron Biosolutions proprietary expression vector technology optimizes production of clients’ proteins and will make possible amounts suitable for crystallography even for proteins that normally are difficult to express. SARomics Biostructures has a strong track record of solving customers’ crystal structures and by combining the expertise from both companies the joint service will leverage their joint potential to meet clients’ structural biology needs.
“We are very pleased with this collaboration. Now we are able to execute gene-to-structure projects in an efficient way that our customers will benefit from”, says Dr. Derek Logan, Chief Scientific Officer of SARomics Biostructures AB.
“We are very excited to combine our innovative gene expression platform with SARomics’ expertise in protein structure determination, and are confident this will add greater value to our customers”, says Dr. Trond Erik Vee Aune, CEO of Vectron Biosolutions AS.
Ämnen
- Partnerskap, samarbeten
Kategorier
- läkemedelsutveckling
- structure-based drug design
- drug discovery
- kontraktsforskning
- forskningsservice
- proteiner
About Vectron Biosolutions
Through a combination of experienced life science researchers, state-of-the-art laboratory facilities, a proprietary technology platform and competent management, Vectron Biosolutions AS supplies the life sciences with superior technology and solutions. The company focuses on developing broad-host-range vector technology, especially expression vectors for industrial level production of recombinant proteins. In addition to providing innovative vector technology, Vectron Biosolutions AS offers its own life science research services, including recombinant protein production, vector development and molecular engineering of proteins and nucleic acids.
For more information, please visit www.vectronbiosolutions.com.
About SARomics Biostructures
SARomics Biostructures AB is the leading Scandinavian provider of structural biology and in silico drug discovery services. The privately held company accelerates its customers’ drug discovery processes by providing contract R&D support in the areas of protein crystallization, protein structure determination, NMR spectroscopy and computational chemistry. SARomics Biostructures is equipped with state-of-the-art robotics for low volume, high-throughput crystallization and X-ray diffraction experiments. Its strategic location close to the MAX-lab synchrotron radiation facility in Lund, Sweden provides instant access to beamlines for data collection enabling rapid project turnaround.
For further general information please visit www.saromics.com or contact Dr. Björn Walse, Director Sales & Marketing, sales@saromics.com, tel. +46 46 191276.
